New clinical study demonstrates TRUCLEAR 5.0 System as a favorable treatment for a common gynecological condition, right in the doctor's office
Smith & Nephew today announces the results of a new multicenter clinical study which compares the TRUCLEAR 5.0 System with the VersaPoint™ Bipolar Electrosurgery System for the removal of endometrial polyps
read more...

Smith & Nephew expands uterine care portfolio with innovative diagnostic device
Smith & Nephew, the global medical technology business, today announces an agreement with Femasys Inc., the medical device developer of women’s healthcare solutions, to become the sole provider in the United States of Femasys’ FemVue® Saline-Air Device
read more...

New technology from Smith & Nephew offers more efficient uterine fibroid removal
Smith & Nephew (LSE:SN NYSE:SNN), the global medical technology business, today introduced the newest addition to its innovative TRUCLEAR™ System, the TRUCLEAR ULTRA Reciprocating Morcellator 4.0
Press Release – December 18, 2012
read more...